Teladoc Health will announce Q4 2024 results on February 26, 2025, followed by a conference call at 4:30 p.m. ET.
Quiver AI Summary
Teladoc Health Inc. has announced it will release its fourth quarter 2024 financial results on February 26, 2025, after market close. The company will hold a conference call at 4:30 p.m. ET on the same day to discuss the results, with participation details provided for both U.S. and international callers. A live audio webcast will also be available, along with a replay accessible for about 90 days after the event. Teladoc Health emphasizes its commitment to improving healthcare experiences through virtual care, utilizing extensive expertise and data-driven approaches to enhance health outcomes for individuals at all stages of their health journey.
Potential Positives
- Teladoc Health is set to release its fourth quarter 2024 results on February 26, 2025, which may provide insights into the company’s performance and growth potential.
- The scheduled conference call will allow investors and analysts to engage directly with company leadership, fostering transparency and open communication.
- The company's status as a global leader in virtual care is reinforced, highlighting its commitment to improving health outcomes and innovating within the healthcare space.
Potential Negatives
- Failure to disclose any significant financial metrics or performance indicators in advance of the earnings call could lead to investor uncertainty and negative market speculation.
- The mention of scheduled earnings release suggests potential volatility in stock price, unless strong results are anticipated.
- The press release does not address any ongoing challenges or market conditions that could impact results, raising concerns about transparency and communication with investors.
FAQ
When will Teladoc Health release its fourth quarter 2024 results?
Teladoc Health will release its fourth quarter 2024 results on February 26, 2025, after the market closes.
What time is the Teladoc conference call?
The Teladoc conference call will take place at 4:30 p.m. ET on February 26, 2025.
How can I join the Teladoc conference call?
Dial 1-833-470-1428 for U.S. participants and use access code # 259200 to join the call.
Is there a way to listen to the call online?
Yes, a live audio webcast of the call will be available at https://ir.teladoc.com/news-and-events/events-and-presentations/.
How long will the call replay be available?
The replay of the call will be available for on-demand listening for approximately 90 days after the event.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$TDOC Insider Trading Activity
$TDOC insiders have traded $TDOC stock on the open market 27 times in the past 6 months. Of those trades, 4 have been purchases and 23 have been sales.
Here’s a breakdown of recent trading of $TDOC stock by insiders over the last 6 months:
- FERNANDO M. RODRIGUES (President of BetterHelp) has made 0 purchases and 2 sales selling 21,964 shares for an estimated $249,902.
- MALA MURTHY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 2 sales selling 17,533 shares for an estimated $167,439.
- ANDREW TURITZ (EVP, CORPORATE DEVELOPMENT) has made 0 purchases and 2 sales selling 22,390 shares for an estimated $162,396.
- STEPHANY VERSTRAETE (CHIEF MARKETING OFFICER) has made 0 purchases and 2 sales selling 17,083 shares for an estimated $128,922.
- THOMAS MCKINLEY has made 3 purchases buying 15,000 shares for an estimated $112,502 and 0 sales.
- ADAM C VANDERVOORT (CHIEF LEGAL OFFICER, SECRETARY) has made 0 purchases and 2 sales selling 6,821 shares for an estimated $67,936.
- CARLOS NUENO (President, International) has made 0 purchases and 2 sales selling 5,279 shares for an estimated $60,948.
- KELLY BLISS (President, U.S. Group Health) has made 0 purchases and 2 sales selling 2,937 shares for an estimated $32,114.
- MICHAEL WILLEM WATERS (CHIEF OPERATING OFFICER) sold 4,218 shares for an estimated $30,217
- MARK DOUGLAS SMITH purchased 4,000 shares for an estimated $28,312
- VIDYA RAMAN-TANGELLA (CHIEF MEDICAL OFFICER) has made 0 purchases and 3 sales selling 3,119 shares for an estimated $22,644.
- ARNNON GESHURI (CHIEF PEOPLE OFFICER) sold 1,795 shares for an estimated $12,859
- DANIEL TRENCHER (CHIEF STRATEGY OFFICER) sold 1,777 shares for an estimated $12,730
- NIKOLAOS P. NANIS (Chief Technology Officer) has made 0 purchases and 2 sales selling 1,239 shares for an estimated $8,870.
- JAMES L. CAVE (INTERIM CAO) sold 555 shares for an estimated $3,976
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$TDOC Hedge Fund Activity
We have seen 149 institutional investors add shares of $TDOC stock to their portfolio, and 225 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARK INVESTMENT MANAGEMENT LLC removed 7,481,255 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $68,677,920
- GOLDMAN SACHS GROUP INC added 5,438,218 shares (+1069.8%) to their portfolio in Q3 2024, for an estimated $49,922,841
- NIKKO ASSET MANAGEMENT AMERICAS, INC. removed 4,136,936 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $37,977,072
- CLEARLINE CAPITAL LP removed 3,844,861 shares (-88.1%) from their portfolio in Q3 2024, for an estimated $35,295,823
- BLACKROCK, INC. removed 3,387,936 shares (-15.7%) from their portfolio in Q3 2024, for an estimated $31,101,252
- POINT72 ASSET MANAGEMENT, L.P. added 3,063,172 shares (+57.8%) to their portfolio in Q3 2024, for an estimated $28,119,918
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 1,731,303 shares (-82.4%) from their portfolio in Q3 2024, for an estimated $15,893,361
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
PURCHASE, NY, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release fourth quarter 2024 results on Wednesday, February 26, 2025, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. ET on the same day.
Conference Call Details
The conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 259200. For international participants, please visit the following link for global dial-in numbers:
https://www.netroadshow.com/events/global-numbers?confId=72270
. A live audio webcast will also be available online at
https://ir.teladoc.com/news-and-events/events-and-presentations/
.
A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.
About Teladoc Health
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Teladoc Health leverages more than two decades of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit
www.teladochealth.com
.
Investors:
Michael Minchak
[email protected]
617-444-9612